Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 23, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 19,315 | $4.21 | $81,316.15 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 593,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:21 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-007129 · tm264253-3_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,505 F1 · kind: On January 23, 2026, the Reporting Person made a charitable donation of 6,000 shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:19 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 13,151 | $82.42 | $1,083,905.42 |
DisclosureSEC source: 0001104659-26-007127 · tm264253-1_4seq1.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,115 F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $82.665 to $84.64. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 22:16 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 34,438 | $82.48 | $2,840,446.24 |
DisclosureSEC source: 0001104659-26-005442 · tm263774-2_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 580,505 F1 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 22:15 UTC |
Ali AsifChief Financial Officer
|
SaleCommon Stock | 8,588 | $82.48 | $708,338.24 |
DisclosureSEC source: 0001104659-26-005440 · tm263774-1_4seq1.xml · nonDerivative · entry 1 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,077 F1 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 22:17 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 9,514 | $82.48 | $784,714.72 |
DisclosureSEC source: 0001104659-26-005443 · tm263774-3_4seq1.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,266 F1 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:45 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,299 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001104659-26-003386 · tm263110-1_4seq1.xml · derivative · entry 2 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,299 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:45 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionCommon Stock | 14,299 | $4.21 | $60,198.79 |
DisclosureSEC source: 0001104659-26-003386 · tm263110-1_4seq1.xml · nonDerivative · entry 1 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:38 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 120,200 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001474 · tm262304-3_4seq1.xml · derivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,200 Underlying: Common Stock · 120,200 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:38 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantCommon Stock | 95,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001474 · tm262304-3_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614,943 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:37 UTC |
Ali AsifChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001472 · tm262304-2_4seq1.xml · derivative · entry 2 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:37 UTC |
Ali AsifChief Financial Officer
|
GrantCommon Stock | 25,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001472 · tm262304-2_4seq1.xml · nonDerivative · entry 1 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,665 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 19:39 UTC |
O'Dowd Sarah ADirector
|
GrantStock Option (right to buy) · Derivative | 3,762 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001475 · tm262304-4_4seq1.xml · derivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,762 Underlying: Common Stock · 3,762 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 19:39 UTC |
O'Dowd Sarah ADirector
|
GrantCommon Stock | 2,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001475 · tm262304-4_4seq1.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,825 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:44 UTC |
SELICK HAROLD EDirector
|
GrantStock Option (right to buy) · Derivative | 3,762 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001479 · tm262304-8_4seq1.xml · derivative · entry 2 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,762 Underlying: Common Stock · 3,762 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:44 UTC |
SELICK HAROLD EDirector
|
GrantCommon Stock | 2,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001479 · tm262304-8_4seq1.xml · nonDerivative · entry 1 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,546 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:42 UTC |
Waddill William D.Director
|
GrantStock Option (right to buy) · Derivative | 3,762 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001478 · tm262304-7_4seq1.xml · derivative · entry 2 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,762 Underlying: Common Stock · 3,762 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:42 UTC |
Waddill William D.Director
|
GrantCommon Stock | 2,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001478 · tm262304-7_4seq1.xml · nonDerivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,825 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:41 UTC |
Giraudo BryanDirector
|
GrantStock Option (right to buy) · Derivative | 3,762 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001477 · tm262304-6_4seq1.xml · derivative · entry 3 Giraudo Bryan · CIK 0001740847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,762 Underlying: Common Stock · 3,762 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:41 UTC |
Giraudo BryanDirector
|
GrantCommon Stock | 2,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001477 · tm262304-6_4seq1.xml · nonDerivative · entry 1 Giraudo Bryan · CIK 0001740847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,825 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:40 UTC |
Williams Lewis TDirector
|
GrantStock Option (right to buy) · Derivative | 3,762 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001476 · tm262304-5_4seq1.xml · derivative · entry 2 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,762 Underlying: Common Stock · 3,762 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:40 UTC |
Williams Lewis TDirector
|
GrantCommon Stock | 2,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001476 · tm262304-5_4seq1.xml · nonDerivative · entry 1 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,825 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:35 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $87.18 | $0.00 |
DisclosureSEC source: 0001104659-26-001471 · tm262304-1_4seq1.xml · derivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-01-02 F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:35 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantCommon Stock | 25,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-001471 · tm262304-1_4seq1.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,780 F1 · shares: Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 21:01 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-115399 · tm2532034-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 519,543 F1 · kind: This transaction involves a bona fide gift of securities from the Reporting Person to his grandchild. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:01 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 2,712 | $84.77 | $229,896.24 |
DisclosureSEC source: 0001104659-25-114082 · tm2531619-1_4seq1.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,180 F1 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 20:01 UTC |
Waddill William D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001104659-25-099252 · tm2528674-1_4seq1.xml · derivative · entry 4 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2028-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 20:01 UTC |
Waddill William D.Director
|
SaleCommon Stock | 8,000 | $87.81 | $702,480.00 |
DisclosureSEC source: 0001104659-25-099252 · tm2528674-1_4seq1.xml · nonDerivative · entry 3 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,130 F1 · kind: Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023. F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $86.71 to $88.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 20:01 UTC |
Waddill William D.Director
|
SaleCommon Stock | 4,000 | $69.25 | $277,000.00 |
DisclosureSEC source: 0001104659-25-099252 · tm2528674-1_4seq1.xml · nonDerivative · entry 2 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,130 F1 · kind: Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 20:01 UTC |
Waddill William D.Director
|
Exercise / conversionCommon Stock | 12,000 | $6.98 | $83,760.00 |
DisclosureSEC source: 0001104659-25-099252 · tm2528674-1_4seq1.xml · nonDerivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2025 Filed Sep 25, 2025 00:35 UTC |
Waddill William D.Director
|
SaleCommon Stock | 4,000 | $64.25 | $257,000.00 |
DisclosureSEC source: 0001104659-25-093046 · tm2526819-1_4seq1.xml · nonDerivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,130 F1 · kind: Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 21:35 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-091352 · tm2526384-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 519,983 F1 · kind: This transaction involves a bona fide gift of securities from the Reporting Person to his son. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 21:30 UTC |
Waddill William D.Director
|
SaleCommon Stock | 4,000 | $59.25 | $237,000.00 |
DisclosureSEC source: 0001104659-25-085795 · tm2524772-1_4seq1.xml · nonDerivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,130 F1 · kind: Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 22:08 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 10,415 | $54.78 | $570,533.70 |
DisclosureSEC source: 0001104659-25-071262 · tm2521838-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520,603 F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $54.75 to $54.82. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 23, 2025 Filed Jul 23, 2025 22:57 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 17,520 | $54.79 | $959,920.80 |
DisclosureSEC source: 0001104659-25-070104 · tm2521572-1_4seq1.xml · nonDerivative · entry 4 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531,018 F4 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $54.75 to $55.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 22, 2025 Filed Jul 23, 2025 22:57 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 22,065 | $55.05 | $1,214,678.25 |
DisclosureSEC source: 0001104659-25-070104 · tm2521572-1_4seq1.xml · nonDerivative · entry 3 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 548,538 F3 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.00 to $55.19. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 22:57 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 12,859 | $54.86 | $705,444.74 |
DisclosureSEC source: 0001104659-25-070104 · tm2521572-1_4seq1.xml · nonDerivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,603 F2 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of PSUs. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 22:57 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-070104 · tm2521572-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 583,462 F1 · shares: Represents settlement by the Issuer of performance stock units ("PSUs") granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan on February 26, 2021, which vested based on the Issuer's achievement of corporate performance objectives. Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 20:01 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-069011 · tm2521210-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 558,462 F1 · kind: On July 16, 2025, the Reporting Person made a charitable donation of 5,000 shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes. F2 · balance_after: Includes an aggregate of 557 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 7, 2025. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 20:01 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 685 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-060239 · tm2518201-1_4seq1.xml · nonDerivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 562,905 F1 · kind: This transaction involves a bona fide gift of securities from the Reporting Person to his grandchildren. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:01 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 670 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-060239 · tm2518201-1_4seq1.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563,590 F1 · kind: This transaction involves a bona fide gift of securities from the Reporting Person to his grandchildren. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:40 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001104659-25-058597 · tm2517775-1_4seq1.xml · derivative · entry 6 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,971 Underlying: Common Stock · 10,000 shares Expires 2032-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option represents a right to purchase a total of 127,500 shares of the Issuer's common stock, one quarter of which vested on November 7, 2023, with the remaining three quarters vesting in equal monthly installments through November 7, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:40 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 10,000 | $57.03 | $570,300.00 |
DisclosureSEC source: 0001104659-25-058597 · tm2517775-1_4seq1.xml · nonDerivative · entry 4 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,892 F2 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $56.665 to $57.48. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:40 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $8.04 | $80,400.00 |
DisclosureSEC source: 0001104659-25-058597 · tm2517775-1_4seq1.xml · nonDerivative · entry 3 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:40 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001104659-25-058597 · tm2517775-1_4seq1.xml · derivative · entry 5 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,971 Underlying: Common Stock · 10,000 shares Expires 2032-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option represents a right to purchase a total of 127,500 shares of the Issuer's common stock, one quarter of which vested on November 7, 2023, with the remaining three quarters vesting in equal monthly installments through November 7, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:40 UTC |
MOLINA ARTURO MDChief Medical Officer
|
SaleCommon Stock | 10,000 | $55.51 | $555,100.00 |
DisclosureSEC source: 0001104659-25-058597 · tm2517775-1_4seq1.xml · nonDerivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,892 F1 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.18 to $55.75. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:40 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $8.04 | $80,400.00 |
DisclosureSEC source: 0001104659-25-058597 · tm2517775-1_4seq1.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:45 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,725 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001104659-25-042608 · tm2513710-1_4seq1.xml · derivative · entry 2 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,725 shares Expires 2025-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These stock options are fully vested. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:45 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionCommon Stock | 10,725 | $1.16 | $12,441.00 |
DisclosureSEC source: 0001104659-25-042608 · tm2513710-1_4seq1.xml · nonDerivative · entry 1 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 20:30 UTC |
Ali AsifChief Financial Officer
|
SaleCommon Stock | 1,756 | $46.00 | $80,776.00 |
DisclosureSEC source: 0001104659-25-038036 · tm2513020-1_4seq1.xml · nonDerivative · entry 1 Ali Asif · CIK 0001921163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,065 F1 · shares: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.